Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,685.43
+29.831.12%
Number of Gainers:57
Number of Losers:39
Number of Flat:2
PE:- -
High:2,697.11
Open:2,655.45
Low:2,655.45
Close:2,655.60
Volume:1.18B
Turnover:239.15B
Market Cap:49.12T
Float Cap:45.71T

Loading ...

Update - Dividend/Distribution - NEM-NEM.N

Reuters
·
Sep 30

Costco Earnings Call Highlights Growth, Global Expansion

TIPRANKS
·
Sep 30

Review & Preview: Yields Beat Doves

Dow Jones
·
Sep 30

Tesla (TSLA.US) Secures $30 Billion in Backup Credit as FSD Experience Leaps Forward and Optimus Humanoid Robot Races Toward Mass Production, Accelerating Musk's "Physical AI Super Ambition"

Stock News
·
Sep 30

Tesla Lines up $30 Billion Credit Lines as Capex, AI Push Accelerate

Reuters
·
Sep 30

Codan Limited (CODAF) Receives a Buy from MA Financial Group

TIPRANKS
·
Sep 30

Why Kroger is Trying to be More Like Walmart

Dow Jones
·
Sep 30

AJ Lucas Sets November Date for 2026 AGM and Director Nominations

TIPRANKS
·
Sep 30

JPMorgan Group Exits Substantial Holder Position in Minerals 260

TIPRANKS
·
Sep 30

He was Rejected by Goldman Out of College. Now He's Poised to Run the Bank.

Dow Jones
·
Sep 30

Trump Defends Light-Touch AI Strategy After Industry Sounds Alarms

Dow Jones
·
Sep 30

Goldman Private Credit Fund Defies Industry Elevated Withdrawal Trend Again yet Again

Reuters
·
Sep 30

Trump Unveils AI-Powered America.gov Portal, Meets Industry Leaders; OpenAI Launches Always-On Assistant Dots; Apple's New CEO Pursues Internal Overhaul

Deep News
·
Sep 30

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

TIPRANKS
·
Sep 30

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Reuters
·
Sep 30

Top 20 US Stock Trades by Volume on September 30: Micron Gains Over 1%, Q4 Earnings Due After Wednesday's Close

Deep News
·
Sep 30

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS
·
Sep 30

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Sep 30

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS
·
Sep 30

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS
·
Sep 30